Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
2019 third quarter results announcement
We announced our third quarter results for the period ended 30 September 2019 on Wednesday 30 October.
Latest information
Press releases
- EACS 2019: ViiV Healthcare to present 17 abstracts from its portfolio addressing the diverse needs of people living with HIV
- GSK delivers sales of £9.4 billion +16% AER, +11% CER (Pro-forma +6% CER*)
- Intravenous Benlysta is the first biologic treatment to be approved for children with lupus in Europe
Annual Report 2018
We published our Annual Report 2018 on 12 March 2019. View the summary and download the full report or individual sections.